NCT06931275View on ClinicalTrials.gov

Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

1,178

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

July 30, 2027

Study Completion Date

July 30, 2027

Conditions
Diabetes Mellitus, Type 1
Interventions
OTHER

EMR-based BPA model

Advanced Diabetes Technologies including AIDs, insulin pumps and CGMs will be prescribed to patients after an EMR-based BPA implementation at six centers.

BEHAVIORAL

Placebo (EMR-based without BPA model)

Advanced Diabetes Technologies including AIDs, insulin pumps and CGMs will be prescribed to patients after an EMR-based system without BPA at the implementation at six centers.

Trial Locations (2)

02110

RECRUITING

T1D Exchange, Boston

02111

NOT_YET_RECRUITING

T1D Exchange, Boston

All Listed Sponsors
lead

T1D Exchange, United States

OTHER